Global Mycoplasma Testing Market (2020 to 2024) - Featuring Agilent Technologies, ATCC & Becton Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Mycoplasma Testing Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The mycoplasma testing market is poised to grow by $ 445.57 million during 2020-2024 progressing at a CAGR of 11% during the forecast period.

The reports on mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing focus on R&D of biopharmaceuticals, increasing initiatives and funding for mycoplasma testing and rise in adoption of real-time mycoplasma testing.

The mycoplasma testing market analysis includes end-user segment and geographic landscapes. This study identifies the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, increasing healthcare expenditure and technological advances will lead to sizable demand in the market.

Companies Mentioned

• Agilent Technologies Inc.
• ATCC
• Becton
• Dickinson and Co.
• Charles River Laboratories International Inc.
• F. Hoffmann-La Roche Ltd.
• InvivoGen
• Lonza Group Ltd.
• Merck KGaA
• Norgen Biotek Corp.
• Thermo Fisher Scientific Inc.

The mycoplasma testing market covers the following areas:

• Mycoplasma testing market sizing
• Mycoplasma testing market forecast
• Mycoplasma testing market industry analysis

Key Topics Covered:

1. Executive Summary

• Market Overview

2. Market Landscape

• Market ecosystem
• Value chain analysis

3. Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

• Five Force Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

5. Market Segmentation by Product

• Market segments
• Comparison by Product
• Consumables - Market size and forecast 2019-2024
• Systems - Market size and forecast 2019-2024
• Market opportunity by Product

6. Market Segmentation by End-user

• Pharmaceutical and biotechnology companies
• CROs
• Academic research institutes
• Cell banks
• Others

7. Customer Landscape

8. Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Volume driver - demand led growth
• Market challenges
• Market trends

9. Vendor Landscape

• Vendor landscape
• Landscape disruption
• Competitive scenario

10. Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Agilent Technologies Inc.
• ATCC
• Charles River Laboratories International Inc.
• F. Hoffmann-La Roche Ltd.
• InvivoGen
• Lonza Group Ltd.
• Merck KGaA
• Norgen Biotek Corp.
• Thermo Fisher Scientific Inc.

11. Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/e8n5n2